BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Friday, July 4, 2025
Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 12, 2019

View Archived Issues

Targeting lymph node stage may nip metastases in the bud

Read More

Genome editing used to create models of GM1-gangliosidosis and Morquio syndrome type B

Read More

Free radicals can benefit the brain

Read More

Urethral macrophages are HIV reservoir

Read More

Xiamen University describes triggering receptor expressed on myeloid cells 2 polypeptides

Read More

Rho-associated protein kinase 1/2 inhibitors disclosed by Kadmon

Read More

Curigin patents nucleic acid molecules inhibiting MTOR and AR gene expression

Read More

Beijing Sanyou Liheze Biological Technology describes anticoagulant fusion protein

Read More

HDAC3 is a novel therapeutic target for ischemic stroke

Read More

Results presented from phase I/II CHAMPIONS study of SB-913

Read More

New biomarkers discovered tied to intracranial aneurysm

Read More

ADAR1-editing of cell-cycle-regulatory miRNAs is involved in progenitor malignant transformation

Read More

Tumor-specific near-infrared agent targeting PSMA for fluorescence-guided surgery in prostate cancer

Read More

Sterol regulatory element binding protein as a potential target for broad-spectrum antiviral agents

Read More

Viral-mediated TMBIM6 gene delivery protects against neonatal hypoxic ischemia

Read More

European Commission extends marketing authorization for Adcetris

Read More

Sprycel receives European approval in pediatric patients with newly diagnosed Ph+ ALL

Read More

Patient enrollment ongoing in phase I study of SER-401 in combination with nivolumab

Read More

FDA approves IND for ABBV-0805 for Parkinson's disease

Read More

Ascendis announces phase II trial of TransCon PTH to treat hypoparathyroidism

Read More

Increased miR-9 levels in CSF found to be a poor prognostic factor after subarachnoid hemorrhage

Read More

Bicycle awarded contract to identify novel inhibitors of PBPs of key bacterial pathogens

Read More

3SBio and Verseau collaborate in immuno-oncology

Read More

STELLAR-4 trial of selonsertib in compensated cirrhosis due to NASH does not meet week 48 endpoint

Read More

Redx's preclinical ROCK-II compound suppresses collagen deposition and pathways linked to fibrosis

Read More

Aduro doses first patient with ADU-S100 and Yervoy for melanoma in phase I trial

Read More

New phase III trial in China studies HC-1119 for metastatic CRPC

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 3, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 3, 2025.
  • News in brief

    BioWorld Asia
    BioWorld Asia briefs for July 1, 2025
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • Robert Paris, vice president, Moderna

    Moderna expands mRNA tech to latent viruses, cancer, rare disease

    BioWorld
    Post pandemic, Moderna Inc. is broadening the applications of mRNA technology to cancer, rare diseases, latent viruses and respiratory viruses, “taking advantage”...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing